Mucinous Ovarian Cancer Research

MOCC Grant Program


Founded in late 2020, the Mucinous Ovarian Cancer Coalition was created, in part, to provide grants to investigators working toward a cure for this rare disease. While we are a small, all-volunteer organization, we have ambitious goals for funding research.
 
MOCC is committed to working with partners who will advance the development of screening tests and treatment options. Our ultimate goal is to find a cure for this disease. To that end, the request for proposals for Rhonda’s Award 2027 begins on March 2, 2026.

Rhonda's Award 2027 Increases to $100,000

As the name of this grant implies, Rhonda was the cofounder of the Mucinous Ovarian Cancer Coalition and she continues to be the inspiration for our work. Rhonda battled this rare type of ovarian cancer with grace and empathy, always looking for ways to support other women diagnosed with the disease. Her spirit and positive approach to life guides us each day.

For this funding cycle, we would also like to recognize and thank the families of several young women whose journeys ended far too soon. The loved ones of Kate Kaplan and Wendy Tam have joined our fundraising efforts. And we also thank survivor, Amanda Laughlin, for her tireless work raising money for this award.

For the 2027 funding year, MOCC will consider proposals specific to Mucinous ovarian cancer research in amounts up to $100,000. Special consideration will be given to those with a goal of identifying innovative approaches to treating advanced stages of this rare disease or a recurrence. The MOCC Physician Advisory Committee will use a modified version of the NIH scale for grading proposals.



 

Call for Proposals for Rhonda's Award 2027

The timeline for the grant review process is as follows:

· March 2, 2026: Call for abstracts opens. Investigators are invited to submit abstracts for proposals up to $100,000. Please include a description of and rationale for the research. Abstracts should be limited to 300 words. We also request that you attach a biosketch for the principal and co-investigators. Those who are interested in applying should send documents in a PDF format to Hope4MOC@gmail.com

· April 3, 2026: Deadline for conveying abstracts. Documents must be received by 9:00 a.m. (EST) on Friday, April 3, 2026

 · April 6 - May 4 2026: MOCC Physician Advisory Board reviews abstracts and determines which investigators should be invited to submit a full proposal.

 · May 11, 2026: Applicants are notified of status no later than May 11th. Those invited to proceed will be asked to send a full proposal, not to exceed six pages (excluding addenda). The proposal should include a project narrative summary, a budget with direct costs detailed, a timeline, and any additional sources of financial support.  

· June 15, 2026: Deadline for submitting full proposal. Documents must be received in PDF format by 9:00 a.m. (EST).

  · June 22 - August 1, 2026: MOCC Physician Advisory Board reviews full proposals and makes a recommendation to the MOCC Board of Directors for the recipient of Rhonda's Award 2027

.· August 14, 2026: Applicants will be notified of decisions no later than August 14th. 

· September 17, 2026: MOCC will make a public announcement of the recipient of the Rhonda's Award 2027 on September 17th, the birthday of our late cofounder. 

Post-Announcement Timeline

 · First disbursement of funds goes out after the contract is signed.
        Target date: February 1, 2027
 · Interim progress report is due six months after funds are disbursed.
        Target date: August 2, 2027
 · Final disbursement of funds will be transmitted after the Physician Advisory Committee reviews the interim report.
        Target date: August 16, 2027
 · Final project report is due six months after last transfer of funds.
        Target date: February 1, 2028
Please visit our Frequently Asked Questions page for more details on our grant application guidelines or email Hope4MOC@gmail.com with any additional questions.
Donate